
Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2009
-
By Christopher P. Singer — As widely publicized, U.S. Patent and Trademark Office Director David Kappos launched a blog earlier this month that is intended to engage the public and provide updates regarding USPTO news (see "Director Kappos Joins Blogger Ranks"). In an article posted on November 24, 2009, Director Kappos announced that the…
-
By Donald Zuhn — In anticipation of the upcoming oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., scheduled for December 7th, we have been reviewing a number of the briefs submitted by various amici. (We learned of an additional amicus brief that was filed last week,…
-
By Donald Zuhn — With oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. scheduled for Monday, December 7, 2009, last Friday marked the deadline for the filing of amicus curiae briefs. Twenty-four amicus briefs were submitted (by our count), with eighteen briefs filed in support of…
-
By Kevin E. Noonan — The three members of the "high technology" community named above have weighed in on the Federal Circuit's en banc review of the written requirement and provide their own unique perspective on a debate that has raged primarily in the biotechnology sector over the past several years (see amicus brief). …
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Athena Diagnostics, Inc. v. Ambry Genetics Corp.4:09-cv-40199; filed November 18, 2009 in the District Court of Massachusetts Infringement of U.S. Patent No. 6,274,310…
-
December 7, 2009 – 20th Annual Conference on U.S. Patent and Trademark Office Law and Practice (PTO Day) (Intellectual Property Owners Association (IPO) and U.S. Patent and Trademark Office) – Washington, DC December 7-8, 2009 – Foreign Patent Law & Regulation*** (American Conference Institute) – New York, NY January 6-10, 2010 – 27th Annual National…
-
Law Education Institute, Inc. (LEI) will be holding the 27th Annual National CLE Conference on January 6-10, 2010 in Vail, Colorado. The Intellectual Property program of the conference, which will be held at the Vail Marriott Resort & Spa, will offer presentations on a number of topics, including: • Federal Circuit and legislative update;• Continued…
-
By Kevin E. Noonan — Christopher M. Holman, Associate Professor of Law at the University of Missouri-Kansas City (and proprietor of Holman's Biotech IP Blog), has filed an amicus brief in support of neither party in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. While not arguing on behalf of either party, Ariad would…
-
By Donald Zuhn — Earlier this month, Donald Chisum (at right), who for the past 31 years has authored the patent treatise Chisum on Patents, was in Chicago to give a luncheon presentation on recent patent law developments to a group of local practitioners. Mr. Chisum, who was professor of law at the University…
-
By Sydney Kokjohn — Patent practitioners concerned about patent term adjustment should pay careful attention to 37 C.F.R. § 1.704(b) concerning applicant delay, especially regarding the date of issue fee payments. This section provides that "an applicant shall be deemed to have failed to engage in reasonable efforts to conclude processing or examination of…